Renexxion
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
325 Sharon Park Dr # 303, Menlo Park, Ca...Phone Number
(650) 924-9895Website
www.renexxion.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Renexxion
Renexxion, Inc. is a US-based biotechnology company focused on delivering innovative drugs for patients with high unmet needs in gastrointestinal disorders. Their primary product, Naronapride, is designed to address these conditions effectively. The company operates a wholly owned subsidiary in Ireland, Renexxion Ireland Limited, and is led by a team of experienced professionals in pharmaceutical drug development. Renexxion aims to partner with strategic organizations to enhance their innovation and reach in the biotech industry.Explore more
Renexxion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Renexxion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Renexxion is spiking on competitors!
Product Launch: Get notified when Renexxion launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Renexxion has new funding data
Click to see if Renexxion had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Renexxion recently announced quarterly report
Check if Renexxion has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Renexxion
Renexxion, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Renexxion as Masked Content
Find 2 more new buyers
Compare Similar Companies to Renexxion
Compare insights from companies similar to Renexxion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Renexxion is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Renexxion is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Renexxion.
Renexxion Tech Stack
A closer look at the technologies used by Renexxion
See more technologies
Renexxion News & Media
Dr. Falk Pharma and Renexxion Proceed to Late-Stage Development of Naronapride, Moving Towards Approval in the US and Europe, Following Positive Global Phase 2b Results in Gastroparesis
Dr Falk and Renexxion commit to late-stage development following naronapride’s positive P2b results in gastroparesis, a disease with high unmet need.Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
Positive results from global Phase 2b trial evaluating the efficacy, safety, and tolerability of naronapride in adults with gastroparesisDr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
Positive P2b trial results on naronapride show significant, meaningful impact on gastroparesis symptoms; with favorable safety and tolerability profiles.Dr. Falk Pharma and Renexxion Announce Late-Breaker Oral Presentation of Global Phase 2b Gastroparesis Results at Digestive Disease Week (DDW) 2026
Dr Falk and Renexxion selected for late-breaking oral presentation at this year’s DDW, for data from global P2b study of naronapride in gastroparesis.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Renexxion
Sign Up For FreeTo access detailed company insights
Renexxion, Inc. is a US-based biotechnology company focused on delivering innovative drugs for patients with high unmet needs in gastrointestinal disorders. Their primary product, Naronapride, is designed to address these conditions effectively. The company operates a wholly owned subsidiary in Ireland, Renexxion Ireland Limited, and is led by a te... Read More
